Breast conservation after neoadjuvant chemotherapy for stage II carcinoma of the breast Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms
  • Mastectomy, Segmental
  • Neoadjuvant Therapy

abstract

  • Neoadjuvant chemotherapy can be effectively applied to patients with stage II disease, and breast conservation becomes feasible in the majority of patients. When compared with historic controls, the current study suggests a statistically significant overall survival advantage (p < 0.007) at 5 years.

publication date

  • September 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.jamcollsurg.2005.03.015

PubMed ID

  • 16125064

Additional Document Info

start page

  • 327

end page

  • 34

volume

  • 201

number

  • 3